SynthesisPLoS neglected tropical diseases2019
A systematic review of scabies transmission models and data to evaluate the cost-effectiveness of scabies interventions.
Synthesis in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.
- Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Pooled it
- Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021Guideline
- Ectoparasite- and Vector-Borne-Related Dermatoses: A Single-Centre Study with Practical Diagnostic and Management Insights in a One Health Perspective.Journal of clinical medicine · 2026Article
- Scabies as a Neglected Tropical Disease: A Comprehensive Review of Pathogenesis, Epidemiology, Clinical Manifestations, Diagnosis and Treatment.The Yale journal of biology and medicine · 2025Review
- Trichomoniasis and Other Sexually Transmitted Parasitic Diseases in Women.Clinical obstetrics and gynecology · 2025Review
- Prevalence and Clinical Characteristics of Scabies among Patients in Eastern Iran: A Study in Gonabad City, 2024.Journal of arthropod-borne diseases · 2025Article
- Antiparasitic efficacy of geraniol from Apiaceae family in scabies treatment.Scientific reports · 2025Article
- Economic Evaluation of Oral Ivermectin, Alone or in Combination with Permethrin, versus Permethrin, in the Treatment of Classic Scabies in the Philippine Setting.Acta medica Philippina · 2025Article
- Dynamical analysis of scabies delayed epidemic model with second-order global stability.PloS one · 2025Article
- Acceptability of a nationwide scabies mass drug administration (MDA) program in Fiji: a qualitative interview-based study.The Lancet regional health. Western Pacific · 2024Article
- An unusual case of crusted scabies in an immunocompetent adult: A case report.Clinical case reports · 2024Article
- Scabies vaccines: where we stand and challenges ahead.Parasitology research · 2024Review
- Norwegian scabies in human immunodeficiency virus and tuberculosis-infected child: A case report.Narra J · 2024Article
- Crusted Hyperkeratotic Scabies: A Case Report.Cureus · 2023Article
- Prevalence of scabies and associated factors among children aged 5-14 years in Meta Robi District, Ethiopia.PloS one · 2023Article
- Crusted Scabies, a Neglected Tropical Disease: Case Series and Literature Review.Infectious disease reports · 2022Review
- Health care cost of crusted scabies in Aboriginal communities in the Northern Territory, Australia.PLoS neglected tropical diseases · 2022Article
- Laboratory-based diagnosis of scabies: a review of the current status.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2022Review
- Scabies outbreak during COVID-19: an Italian experience.International journal of dermatology · 2021Article
- Risk factors associated with scabies infestation among primary schoolchildren in a low socio-economic area in southeast of Iran.BMC pediatrics · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundScabies is a common dermatological condition, affecting more than 130 million people at any time. To evaluate and/or predict the effectiveness and cost-effectiveness of scabies interventions, disease transmission modelling can be used.
objectiveTo review published scabies models and data to inform the design of a comprehensive scabies transmission modelling framework to evaluate the cost-effectiveness of scabies interventions.
methodsSystematic literature search in PubMed, Medline, Embase, CINAHL, and the Cochrane Library identified scabies studies published since the year 2000. Selected papers included modelling studies and studies on the life cycle of scabies mites, patient quality of life and resource use. Reference lists of reviews were used to identify any papers missed through the search strategy. Strengths and limitations of identified scabies models were evaluated and used to design a modelling framework. Potential model inputs were identified and discussed.
findingsFour scabies models were published: a Markov decision tree, two compartmental models, and an agent-based, network-dependent Monte Carlo model. None of the models specifically addressed crusted scabies, which is associated with high morbidity, mortality, and increased transmission. There is a lack of reliable, comprehensive information about scabies biology and the impact this disease has on patients and society. DISCUSSION: Clinicians and health economists working in the field of scabies are encouraged to use the current review to inform disease transmission modelling and economic evaluations on interventions against scabies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.